GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, KIT, MMP9, PTGES, RELA, SRC, TERT |
11.041 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD2, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, HSD17B3, KIT, MET, PPARA, PTGES |
10.0428 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
9.69609 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
9.69609 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APP, AR, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SRC, TYR |
9.69418 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TYR |
9.48926 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MMP2, PPARA, PTGES, RELA, RORC, SRC, TYR |
9.44278 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SRC, TERT, TYR |
9.364 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
9.25815 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
9.08753 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
8.27583 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, PTGES, RELA, RORC, SRC, TYR |
8.13297 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, F3, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSD17B3, KDR, KIT, MAOA, MET, PPARA, SRC, TERT, TNKS, TNKS2, XDH |
7.9823 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CBR1, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, FABP4, FLT3, FUT7, HSD17B2, HSD17B3, KDR, KIT, MAP2K1, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, RELA, RORC, SRC, TERT, TNKS2, TYR |
7.9823 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FUT7, HSD17B3, PIM1, PPARA, PTGES, TYR, XDH |
7.95004 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, HSD17B3, MAOA, TYR |
7.81101 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
7.78213 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.55717 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, PTGES, RELA, RORC, SRC, TYR |
7.34754 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.29097 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
7.28838 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, HSD17B3, KDR, KIT, MAP2K1, PPARA, PTPRS, RELA, SRC, TYR |
7.24665 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.18633 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, KIT, MMP9, PTGES, TERT |
7.18444 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD2, FABP3, FABP4, FUT7, KIT, MET, PPARA, PTGES |
7.18444 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, XDH |
7.10365 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
7.10323 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, RELA, RORC, SRC, TERT |
7.08896 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, FABP3, FLT3, IGF1R, KIT, MMP2, PPARA, RELA, SRC |
7.08896 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, AKR1C3, APP, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, DRD2, F3, FABP3, FLT3, IGF1R, KDR, KIT, MAP2K1, MMP2, MMP9, PIM1, PTGES, RELA, SRC, TERT, XDH |
7.04962 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
7.00586 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.95756 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, FLT3, HSD17B2, HSD17B3, KDR, KIT, MAP2K1, MMP9, PIM1, PPARA, PTPRS, RELA, RORC, SRC, TYR |
6.67484 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, RELA, RORC, SRC |
6.36605 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
6.32719 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
6.26981 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PTPN1, RELA, RORC, SRC, TERT |
6.18512 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, XDH |
6.18512 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
6.12304 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
6.044 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FABP4, FLT3, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
6.03214 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
5.97122 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.95199 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.92047 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
5.89472 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.86375 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.82913 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
5.81215 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT, XDH |
5.70561 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
5.64524 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, PTPN1, RELA, SRC, TERT, XDH |
5.58502 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, PPARA, PTGES |
5.58441 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, KIT, PPARA, RELA, SRC |
5.52586 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, AR, BCL2, CDC25B, CSNK2A1, DRD2, F3, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, RELA, TERT |
5.49585 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
5.295 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
5.20161 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
5.14751 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT |
5.06902 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
5.02883 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, F3, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TERT, TYR |
4.95969 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, MAOA |
4.94988 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AR, AXL, BCL2, CYP19A1, HSD17B2, HSD17B3, KIT, MAP2K1, SRC |
4.94987 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.93547 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, F3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, PPARA, PTPN1, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.88294 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, F3, FABP4, HSD17B2, IGF1R, KIT, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SRC, TNKS2, TYR |
4.86772 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, RELA, SRC, TERT |
4.85794 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.78525 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.7148 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
4.69679 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DYRK1A, F3, FLT3, FUT7, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RELA, SRC, TNKS, TNKS2, TYR, XDH |
4.69228 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, DNMT1, DRD2, IGF1R, KDR, KIT, MAP2K1, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
4.60501 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, RELA, SRC |
4.55989 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, KDR, RELA, SRC |
4.39297 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.38983 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, IGF1R, KDR, MAP2K1, MMP9, PIM1, PTPN1, RELA, SRC, TERT, XDH |
4.38551 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.35817 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
4.35817 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DNMT1, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SRC |
4.33652 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, AKR1C3, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, HSD17B1, HSD17B2, HSD17B3 |
4.31173 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.30438 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, AR, DRD2, FLT3, KDR, KIT, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
4.30438 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
4.30438 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
4.30438 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
4.27682 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD1, DRD2, MAOA |
4.24754 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
4.17179 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, MAOA, TYR |
4.14836 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AR, AXL, CYP1B1, DNMT1, DRD1, IGF1R, MMP2, MMP9, RELA, RORC, SRC |
4.13731 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, SRC, TNKS |
4.12799 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1, HSD17B3 |
4.07374 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.07207 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, FLT3, RORC, SRC |
4.06233 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AR, AURKB, BCL2, CYP1A1, FLT3, KIT, MAP2K1, MET, PIM1, SRC, TYR |
4.05565 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APP, BCL2, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.05139 |
[BP] GO:0030334 |
regulation of cell migration
|
APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.04547 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PPARA, PTPN1, SRC, TERT |
4.01629 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SRC, XDH |
4.01629 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3, PTGES |
4.01522 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, APP, CYP19A1, DRD2, DYRK1A, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, MMP2, PPARA, PTPN1, PTPRS, RELA, SRC, TERT, XDH |
4.00766 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DNMT1, DRD2, DYRK1A, F3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SRC, XDH |
3.99763 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.96696 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.93714 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DYRK1A, KIT, PPARA, RORC, SRC |
3.89937 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, KDR, SRC |
3.89624 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.86112 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, F3, KIT, MET, SRC, XDH |
3.85599 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
3.85547 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
3.85547 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.85547 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, HSD17B2, HSD17B3, KIT, MAP2K1, MMP2, MMP9, SRC |
3.85053 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, KDR, SRC, TNKS, TNKS2 |
3.84791 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AKR1C3, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, MAOA, MMP1, MMP2, MMP9, SRC, XDH |
3.83054 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, PPARA, PTGES |
3.82168 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, APP, AR, BCL2, CDC25B, DRD2, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.8177 |
[BP] GO:2000145 |
regulation of cell motility
|
APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.79533 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, AR, BCL2, CA2, FLT3, RELA, SRC |
3.77239 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.76992 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, FABP3, FABP4, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.76312 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.76096 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, HSD17B2, HSD17B3, KIT, MAP2K1, SRC |
3.72718 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, AR, DRD2, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
3.7071 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.65882 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PTPN1, RELA, SRC, TERT |
3.62404 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, KIT, MMP9, TERT |
3.61965 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, APP, AR, BCL2, CDC25B, DRD2, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.61034 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
3.60928 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, KDR, RELA, SRC |
3.60518 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CYP19A1, CYP3A4, HSD17B3, TYR |
3.60019 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, APP, AR, AURKB, BCL2, CDC25B, DRD2, F3, FLT3, KIT, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, TERT, TNKS, XDH |
3.59061 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
3.56642 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, KIT, MMP2, PPARA, RELA, SRC, TERT, TYR |
3.55177 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AR, AXL, BCL2, CBR1, CDC25B, CYP1A1, DRD1, DRD2, FABP4, FLT3, FUT7, KDR, KIT, MAP2K1, MET, MMP2, MMP9, PTPRS, RORC, SRC, TERT |
3.55167 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.51099 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
3.49716 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.49716 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.49716 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.49716 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, RELA, SRC, TYR |
3.48051 |
[BP] GO:0040012 |
regulation of locomotion
|
APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.46667 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
3.41724 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.36838 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
3.35741 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
3.35741 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.35267 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, HSD17B3 |
3.24527 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, AR, DNMT1, DRD1, FLT3, IGF1R, KIT, MMP2, RELA, SRC |
3.23455 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, F3, FLT3, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.23209 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, DRD2, F3, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIM1, RELA, SRC, TERT |
3.22275 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.22275 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.22275 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.21557 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.19097 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, FABP3, FABP4, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.18977 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, F3, FLT3, FUT7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RELA, SRC, TNKS, TNKS2 |
3.18977 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, RELA, SRC, TYR |
3.17698 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, RELA, SRC |
3.17698 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.10598 |
[BP] GO:0019371 |
None
|
AKR1C3, CBR1, PTGES |
3.10598 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, KIT, RELA, TYR |
3.06397 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CBR1, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
3.05504 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, DYRK1A, MAP2K1, TNKS |
3.0256 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.99525 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, PIM1, PPARA, PTGES, TYR |
2.9895 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MMP9, PTPN1, RELA, SRC, TERT |
2.96259 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC |
2.9529 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, BACE1, CA2, CA7, DRD1, DRD2, KIT |
2.91508 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, BACE1, CA2, CA7, DRD1, DRD2, KIT |
2.91508 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.89721 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.89291 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.89291 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.89291 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.89291 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, DYRK1A, MAP2K1, TNKS |
2.87602 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, AR, BCL2, CYP19A1, DRD1, DRD2, DYRK1A, IGF1R, MET, MMP9, PPARA, PTPN1, PTPRS, RELA, SRC, TERT, XDH |
2.85553 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DYRK1A, IGF1R, MET, MMP9, PTPN1, RELA, SRC, XDH |
2.84829 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.83641 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, TNKS, TNKS2 |
2.80396 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, MAOA |
2.7931 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, MAOA |
2.7931 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.7931 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, AKR1C3, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CHRM2, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2 |
2.79062 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, F3, KIT, MET, SRC |
2.78419 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, F3, FABP4, FLT3, IGF1R, KIT, MAP2K1, MAP3K7, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT, TNKS, XDH |
2.77109 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, FABP3, FABP4, FLT3, MET, SRC, TERT |
2.75077 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.74126 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DNMT1, DRD1, DRD2, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC |
2.73123 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, MAP2K1, RELA, TYR |
2.6358 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MAP3K7, MET, MMP2, MMP9, PTPN1, SRC |
2.63075 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HSD17B3, PTGES |
2.63075 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, KIT |
2.62386 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PPARA, PTGES, PTPN1, RELA, SRC, TERT |
2.61561 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, FUT7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
2.61319 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.60743 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, PIM1, PPARA, PTGES, TYR |
2.60743 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.58919 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, MAP2K1, TYR |
2.58279 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, DRD2, F3, KDR, KIT, MAP2K1, PIM1, RELA, SRC, TERT |
2.54254 |
[BP] GO:0050790 |
regulation of catalytic activity
|
APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, F3, FABP4, FLT3, IGF1R, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, TERT, TNKS, XDH |
2.53621 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, PIM1, PPARA, PTGES, TYR |
2.53621 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, RELA, SRC, TERT |
2.5295 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.52176 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.52142 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SRC, XDH |
2.51958 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.49292 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.49292 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
2.49089 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, KIT |
2.49089 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.49089 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, AR, BCL2, DRD1, DRD2, DYRK1A, IGF1R, MET, MMP9, PTPN1, PTPRS, RELA, SRC, TERT, XDH |
2.48575 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, DNMT1, DRD2, IGF1R, KDR, KIT, MAP2K1, MET, MMP1, MMP9, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
2.48191 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9, RORC |
2.47572 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, AR, BCL2, DRD1, DRD2, DYRK1A, IGF1R, MET, MMP9, PTPN1, PTPRS, RELA, SRC, TERT, XDH |
2.47521 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.47374 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, RELA, SRC |
2.46509 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
2.45313 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
AKR1C3, CYP1A1, FABP3, FLT3, KIT, PPARA, RORC, SRC |
2.44333 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
APP, AXL, BCL2, CA1, CSNK2A1, DRD2, F3, FLT3, IGF1R, KDR, KIT, MAP3K7, MET, MMP2, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2 |
2.43405 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
2.42787 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.39608 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, KDR, MAP2K1, PTPN1, SRC |
2.36634 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP3A4, MAOA |
2.36634 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.36634 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.36634 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
AKR1C3, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, FABP4, IGF1R, KDR, MAP2K1, MET, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.36413 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, CDC25B, DRD2, FABP4, FLT3, IGF1R, KIT, MAP2K1, MAP3K7, PTPN1, SRC, TNKS |
2.36366 |
[BP] GO:0044092 |
negative regulation of molecular function
|
APP, AURKB, CSNK2A1, CYP1B1, DRD2, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
2.36289 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, RORC |
2.35671 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.345 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, TERT, TNKS, TNKS2 |
2.345 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.31774 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
2.31512 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.31077 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, RELA, SRC |
2.30318 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.29554 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, DRD1, DRD2, MAP2K1, MMP9, PPARA, PTPN1, SRC, TERT |
2.29386 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.28017 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD1, DRD2 |
2.26454 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, KDR, MAP2K1, SRC |
2.26172 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26172 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.25911 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25911 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC |
2.24255 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
2.23695 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, IGF1R, MMP2, RELA, SRC |
2.23523 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.23425 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21946 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, RELA |
2.2107 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.19793 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DNMT1, DRD1, DRD2, IGF1R, MAP2K1, MET, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2 |
2.19365 |
[BP] GO:1901575 |
None
|
ACHE, AKR1B10, AKR1C3, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, MAOA, XDH |
2.1773 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FABP3, FABP4, KIT, MET |
2.1773 |
[BP] GO:0048169 |
None
|
APP, DRD2, KIT |
2.1736 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, TNKS2 |
2.16766 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DYRK1A, IGF1R, MAP2K1, MAP3K7, MET, PTPN1, PTPRS, TERT, XDH |
2.16109 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD1, DRD2, F3, FABP4, KDR, MAP2K1, MET, PPARA, PTPRS, RELA |
2.16109 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
APP, CDC25B, DRD2, FABP4, FLT3, IGF1R, KIT, MAP2K1, MAP3K7, PTPN1, SRC |
2.1332 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.13123 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.13123 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CACNA1C, CHRM2, CYP1B1, DRD2, F3, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIM1, PTPRS, RELA, SRC, TERT, TNKS2, XDH |
2.12723 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, IGF1R, SRC, TNKS, TNKS2 |
2.11144 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.10581 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.09195 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, FABP3, FABP4, MET |
2.08943 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.08943 |
[BP] GO:0048638 |
regulation of developmental growth
|
APP, AR, BCL2, DRD2, PIM1, PTPRS, TNKS2 |
2.08943 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, KIT |
2.08857 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.08768 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
APP, AURKB, BCL2, CDC25B, DRD2, F3, FLT3, KIT, MAP2K1, MAP3K7, PTPN1, SRC, TERT, TNKS, XDH |
2.08651 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FLT3, FUT7, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.08651 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.08651 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.08651 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.08651 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.08651 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, FABP4, IGF1R, MET, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.08651 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, KIT, RELA, TYR |
2.08191 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.07945 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, APP, AXL, DRD2, PTPN1, SRC |
2.06946 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, MAOA |
2.0624 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, HSD17B3 |
2.0624 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SRC, XDH |
2.05377 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, IGF1R, MMP2, RELA, SRC |
2.04755 |
[BP] GO:0071383 |
None
|
AKR1C3, AR, FLT3, SRC |
2.04091 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.03759 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCL2, CYP1A1, RELA, SRC, TYR |
2.02375 |
[BP] GO:0042181 |
None
|
AKR1C3, CYP19A1, HSD17B3 |
2.02375 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, CDC25B, DRD2, FLT3, KIT, MAP2K1, MAP3K7, PTPN1, SRC, TNKS |
2.01333 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.0023 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, APP, AR, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, F3, FLT3, FUT7, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, TYR |
3.8336 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.49716 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AR, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CBR1, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PTGES, PTPN1, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, TYR, XDH |
3.46989 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, FUT7, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RELA, RORC, SHBG, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
3.25538 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, AKR1B1, AKR1B10, AKR1C3, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, FUT7, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RELA, RORC, SHBG, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
3.23455 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ALOX15, ALPL, APP, AR, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CSNK2A1, DRD1, DRD2, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, PTPRS, SRC, TERT |
2.78473 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, FLT3, HSD17B2, HSD17B3, PTGES, PTPN1 |
2.46689 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, DYRK1A, F3, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PTGES, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
12.8869 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
12.4208 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
12.1188 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.90696 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
7.29097 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4 |
6.68308 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.30214 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, TYR |
6.11459 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, KIT, MAP3K7, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
6.11041 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, PPARA, SRC |
5.96175 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, XDH |
5.70561 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.52586 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
5.295 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.295 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD17B1, HSD17B2, HSD17B3, XDH |
5.06902 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DNMT1, KIT, MAP3K7, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
4.75879 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, TYR |
4.69679 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.66501 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
4.48309 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD17B1, HSD17B2, HSD17B3 |
4.31173 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, SRC |
4.13731 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.12799 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
4.0594 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.0089 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, SRC |
3.97499 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2, HSD17B3 |
3.85494 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2, HSD17B3 |
3.49134 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2, HSD17B3 |
3.37516 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.35319 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.35267 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DYRK1A, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, PTGES, PTPRS, RELA, SRC, TUBB3, XDH |
3.34135 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.29557 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A6, CYP3A4 |
3.1452 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD17B1, PTGES, SRC, XDH |
3.06113 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.99601 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, TERT |
2.91928 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.89291 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.87602 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, HSD17B1, RORC, SHBG |
2.85521 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, XDH |
2.76247 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, CYP3A4, F3, FABP3, FABP4, HSD17B1, PPARA, RORC, SHBG |
2.62338 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.49292 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.49292 |
[MF] GO:0047045 |
None
|
AKR1C3, HSD17B3 |
2.49292 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DRD2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP3K7, MET, MMP9, RELA, TERT, TYR, XDH |
2.44384 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, CDC25B, CSNK2A1, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC |
2.40888 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.25911 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.25911 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.25911 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.13123 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.08651 |